Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
- Conditions
- Acute Lymphoblastic Leukemia, PediatricMetabolism Disorder
- Registration Number
- NCT03035344
- Lead Sponsor
- Aristotle University Of Thessaloniki
- Brief Summary
Study of the intermediate metabolism in children diagnosed with ALL compared to healthy matched controls.
- Detailed Description
The primary cause of this study is to investigate the changes that ALL may cause to the metabolome of pediatric patients, in order to better understand its mechanism of action and target metabolic pathways for potential therapies.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
- Children with a known chronic illness before ALL diagnosis 2) ALL remission 3) Not signed informed consent
- Population description: Patients are recruited from the Pediatric Hematology/Oncology Department of Aristotle University of Thessaloniki (AHEPA hospital) and from the Pediatric Hematology/ Oncology Department of Ippokration Hospital, that host all children diagnosed with ALL in nothern Greece. Matched controls are recruited from outpatient clinic of the 2nd and 4th Pediatric Department of Aristotle University of Thessaloniki.
- Sampling method: Non-probability sample
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in measurement of aminoacids and organic acids between ALL patients and healthy matched controls. Up to six months The title of aminoacids in blood and urine and of organic acids in urine will be measured through Tandem Mass Spectrometry
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Aristotle University of Thessaloniki
🇬🇷Thessaloniki, Greece
Aristotle University of Thessaloniki🇬🇷Thessaloniki, GreeceMaria T. Papadopoulou, MDContact+306932343539mtpapado@gmail.com